Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,315 USD | -1,48% | +12,86% | +115,10% |
Omzet 2024 * | 50,21 mln. 46,91 mln. | Omzet 2025 * | 57,98 mln. 54,16 mln. | Marktkapitalisatie | 397 mln. 370 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -27 mln. -25,22 mln. | Nettowinst (verlies) 2025 * | -27 mln. -25,22 mln. | EV/omzet 2024 * | 7,49 x |
Nettoliquiditeiten 2024 * | 20,23 mln. 18,9 mln. | Nettoschuld 2025 * | 15,47 mln. 14,45 mln. | EV/omzet 2025 * | 7,11 x |
K/w-verhouding 2024 * |
-12,2
x | K/w-verhouding 2025 * |
-14,9
x | Werknemers | 135 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,97% |
Recentste transcriptie over Aquestive Therapeutics, Inc.
1 dag | -1,26% | ||
1 week | +12,86% | ||
Lopende maand | +2,00% | ||
1 maand | +3,95% | ||
3 maanden | +73,80% | ||
6 maanden | +208,16% | ||
Lopend jaar | +115,10% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Barber
CEO | Chief Executive Officer | 48 | 01-07-07 |
A. Toth
DFI | Director of Finance/CFO | 65 | 31-12-20 |
Stephen Wargacki
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Morris
BRD | Director/Board Member | 61 | 10-08-22 |
Santo Costa
CHM | Chairman | 78 | 01-12-15 |
Gregory Brown
BRD | Director/Board Member | 70 | 01-03-07 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 4,345 | -0,80% | 1 337 672 |
22-04-24 | 4,38 | +6,70% | 1 825 960 |
19-04-24 | 4,105 | -8,78% | 2 340 719 |
18-04-24 | 4,5 | +14,80% | 5 784 893 |
17-04-24 | 3,92 | +1,82% | 2 447 890 |
uitgestelde koers Nasdaq, 23 april 2024 om 21:12 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+115,10% | 394 mln. | |
+27,87% | 659 mld. | |
+27,68% | 557 mld. | |
-4,42% | 359 mld. | |
+16,35% | 322 mld. | |
+9,01% | 297 mld. | |
+6,30% | 215 mld. | |
+4,80% | 210 mld. | |
-6,05% | 200 mld. | |
-8,77% | 149 mld. |